Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H7O3 |
Molecular Weight | 187.1715 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | -1 |
SHOW SMILES / InChI
SMILES
OC1=CC2=CC=CC=C2C=C1C([O-])=O
InChI
InChIKey=ALKYHXVLJMQRLQ-UHFFFAOYSA-M
InChI=1S/C11H8O3/c12-10-6-8-4-2-1-3-7(8)5-9(10)11(13)14/h1-6,12H,(H,13,14)/p-1
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0034976 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26983645 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Inactive ingredient | ALCOPAR Approved UseHelminthiasis |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26983645
In a preclinical study, mice received hydroxynaphthoic acid sodium salt (150 mg/kg/day) twice a day for 2 weeks by gavage.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26983645
The stable HEK 293 cell line harboring a reporter gene expressed by human grp78 promoter was treated with PA media containing 300 uM of palmitate to induce ER stress and then serial dilutions of hydroxynaphthoic acid were applied (from 0.01 to 1 mM) for 22 h. The drug inhibited ER stress with IC50 value of 44.9 uM. It also reduced PA-induced p-JNK and p-IRS-1(S307) levels in dose-dependent manners in HepG2 cells when incubated for 2 h at concentrations 0.1, 0.3, 0.5 mM. At 0.3 mM hydroxynaphthoic acid restored insulin sensitivity suppressed by PA. When fully differentiated 3T3-L1 cells were co-incubated with or without thapsigargin (Tg) and hydroxynaphthoic acid (30, 100, 300 uM) for 18 h, the acid augmented GLUT4 translocation by sensitizing insulin and PPARgamma signaling and showed 100-fold activation at 300 uM. The drug (0.1 and 0.3 mM) protected INS-1 cells from cell death after the incubation with 300 uM PA in combination with 25 mM glucose for 18 h.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID3043992
Created by
admin on Fri Dec 15 21:13:31 GMT 2023 , Edited by admin on Fri Dec 15 21:13:31 GMT 2023
|
PRIMARY | |||
|
54675878
Created by
admin on Fri Dec 15 21:13:31 GMT 2023 , Edited by admin on Fri Dec 15 21:13:31 GMT 2023
|
PRIMARY | |||
|
6OR546GIZX
Created by
admin on Fri Dec 15 21:13:31 GMT 2023 , Edited by admin on Fri Dec 15 21:13:31 GMT 2023
|
PRIMARY | |||
|
776-87-4
Created by
admin on Fri Dec 15 21:13:31 GMT 2023 , Edited by admin on Fri Dec 15 21:13:31 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD